148
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder

&

References

  • Althof, S., DeRogatis, L., & Clayton, A. (2017). Changes in sexual functioning in the bremelanotide RECONNECT study. Journal of Women's Health, 26(4), A13.
  • Altman, D. G., & Royston, P. (2006). The cost of dichotomising continuous variables. BMJ, 332(7549), 1080. https://doi.org/10.1136/bmj.332.7549.1080
  • American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (Third Edition-Revised ed.).
  • American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.).
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
  • Bancroft, J., Graham, C. A., Janssen, E., & Sanders, S. A. (2009). The dual control model: Current status and future directions. The Journal of Sex Research, 46(2–3), 121–142. https://doi.org/10.1080/00224490902747222
  • Bancroft, J., Loftus, J., & Long, J. S. (2003). Distress about sex: A national survey of women in heterosexual relationships. Archives of Sexual Behavior, 32(3), 193–208. https://doi.org/10.1023/a:1023420431760
  • Basson, R. (2000). The female sexual response: A different model. Journal of Sex & Marital Therapy, 26(1), 51–65. https://doi.org/10.1080/009262300278641
  • Bitzer, J., Giraldi, A., & Pfaus, J. (2013). A standardized diagnostic interview for hypoactive sexual desire disorder in women: Standard operating procedure (SOP Part 2). The Journal of Sexual Medicine, 10(1), 50–57. https://doi.org/10.1111/j.1743-6109.2012.02817.x
  • Bogaert, A. F., & Brotto, L. A. (2014). Object of desire self-consciousness theory. Journal of Sex & Marital Therapy, 40(4), 323–338. https://doi.org/10.1080/0092623X.2012.756841
  • Both, S., Everaerd, W., & Laan, E. (2007). Desire emerges from excitement: A psychophysiological perspective on sexual motivation. In E. Janssen (Ed.), The psychophysiology of sex (pp. 327–339). Indiana University Press.
  • Brotto, L. A. (2010). The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Archives of Sexual Behavior, 39(2), 221–239. https://doi.org/10.1007/s10508-009-9543-1
  • Brotto, L. A., Bitzer, J., Laan, E., Leiblum, S., & Luria, M. (2010). Women’s sexual desire and arousal disorders. The Journal of Sexual Medicine, 7(1), 586–614. https://doi.org/10.1111/j.1743-6109.2009.01630.x
  • Brotto, L. A., Graham, C. A., Binik, Y. M., Segraves, R. T., & Zucker, K. J. (2011). Should sexual desire and arousal disorders in women be merged? A response to DeRogatis, Clayton, Rosen, Sand, and Pyke (2010). Archives of Sexual Behavior, 40(2), 221–225. https://doi.org/10.1007/s10508-010-9706-0
  • Brotto, L. A., Petkau, A. J., Labrie, F., & Basson, R. (2011). Predictors of sexual desire disorders in women. The Journal of Sexual Medicine, 8(3), 742–753. https://doi.org/10.1111/j.1743-6109.2010.02146.x
  • Cacioppo, S. (2017). Neuroimaging of female sexual desire and hypoactive sexual desire disorder. Sexual Medicine Reviews, 5(4), 434–444. https://doi.org/10.1016/j.sxmr.2017.07.006
  • Chevance, A., Ravaud, P., Cornelius, V., Mayo-Wilson, E., & Furukawa, T. A. (2022). Designing clinically useful psychopharmacological trials: Challenges and ways forward. The Lancet Psychiatry, 9(7), 584–594. https://doi.org/10.1016/S2215-0366(22)00041-4
  • Chivers, M. L., & Brotto, L. A. (2017). Controversies of women’s sexual arousal and desire. European Psychologist, 22(1), 5–26. https://doi.org/10.1027/1016-9040/a000274
  • Clayton, A. H., Althof, S. E., Kingsberg, S., DeRogatis, L. R., Kroll, R., Goldstein, I., Kaminetsky, J., Spana, C., Lucas, J., Jordan, R., & Portman, D. J. (2016). Bremelanotide for female sexual dysfunctions in premenopausal women: A randomized, placebo-controlled dose-finding trial. Women’s Health (London, England), 12(3), 325–337. https://doi.org/10.2217/whe-2016-0018
  • Clayton, A. H., Dennerstein, L., Fisher, W. A., Kingsberg, S. A., Perelman, M. A., & Pyke, R. E. (2010). Standards for clinical trials in sexual dysfunction in women: Research designs and outcomes assessment. The Journal of Sexual Medicine, 7(1), 541–560. https://doi.org/10.1111/j.1743-6109.2009.01628.x
  • Clayton, A. H., DeRogatis, L. R., Rosen, R. C., & Pyke, R. (2012). Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 2. For women with loss of subjective sexual arousal. The Journal of Sexual Medicine, 9(8), 2040–2046. https://doi.org/10.1111/j.1743-6109.2012.02859.x
  • Clayton, A. H., Goldmeier, D., Nappi, R. E., Wunderlich, G., Lewis-D’Agostino, D. J., & Pyke, R. (2010). Validation of the Sexual Interest and Desire Inventory-Female in hypoactive sexual desire disorder. The Journal of Sexual Medicine, 7(12), 3918–3928. https://doi.org/10.1111/j.1743-6109.2010.02016.x
  • Clayton, A. H., Kingsberg, S. A., Simon, J., Jordan, R., & Lucas, J. (2018). Bremelanotide (BMT) for hypoactive sexual desire disorder (HSDD): Efficacy analyses from the RECONNECT studies. The Journal of Sexual Medicine, 15(S3), S125–126.
  • ClinicalTrials.gov. (2021a). A phase 3, randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension. https://clinicaltrials.gov/ct2/show/NCT02338960
  • ClinicalTrials.gov. (2021b). A phase 3, randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension. https://clinicaltrials.gov/ct2/show/NCT02333071
  • Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Erlbaum.
  • CONSORT. (2020). Endorsers: CONSORT transparent reporting of trials. http://www.consort-statement.org/about-consort/endorsers
  • Corty, E. W., Althof, S. E., & Wieder, M. (2011). Measuring women’s satisfaction with treatment for sexual dysfunction: Development and initial validation of the Women’s Inventory of Treatment Satisfaction (WITS-9). The Journal of Sexual Medicine, 8(1), 148–157. https://doi.org/10.1111/j.1743-6109.2010.01977.x
  • Dawson, S. J., & Chivers, M. L. (2014). Gender differences and similarities in sexual desire. Current Sexual Health Reports, 6(4), 211–219. https://doi.org/10.1007/s11930-014-0027-5
  • DeRogatis, L. R., Clayton, A. H., Goldstein, A., Lewis-D’Agostino, D., Wunderlich, G., & Cotton, D. (2011). EDiary and female sexual distress scale in evaluating distress in hypoactive sexual desire disorder (HSDD). The Journal of Sex Research, 48(6), 565–572. https://doi.org/10.1080/00224499.2010.524321
  • DeRogatis, L. R., Clayton, A., Lewis-D’Agostino, D., Wunderlich, G., & Fu, Y. (2008). Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. The Journal of Sexual Medicine, 5(2), 357–364. https://doi.org/10.1111/j.1743-6109.2007.00672.x
  • DeRogatis, L. R., Clayton, A. H., Rosen, R. C., Sand, M., & Pyke, R. E. (2011). Should sexual desire and arousal disorders in women be merged? Archives of Sexual Behavior, 40(2), 217–219. https://doi.org/10.1007/s10508-010-9677-1
  • DeRogatis, L., Pyke, R., McCormack, J., Hunter, A., & Harding, G. (2011). Does the Female Sexual Distress Scale-Revised cover the feelings of women with HSDD? The Journal of Sexual Medicine, 8(10), 2810–2815. https://doi.org/10.1111/j.1743-6109.2011.02385.x
  • DeRogatis, L. R., Revicki, D. A., Rosen, R. C., Jordan, R., Lucas, J., & Spana, C. (2021). Psychometric validation of the Female Sexual Distress Scale-desire/arousal/orgasm. Journal of Patient-Reported Outcomes, 5(1), 1–11. https://doi.org/10.1186/s41687-021-00359-1
  • Derogatis, L. R., Rosen, R., Leiblum, S., Burnett, A., & Heiman, J. (2002). The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women. Journal of Sex & Marital Therapy, 28(4), 317–330. https://doi.org/10.1080/00926230290001448
  • Dewitte, M., Carvalho, J., Corona, G., Limoncin, E., Pascoal, P., Reisman, Y., & Štulhofer, A. (2020). Sexual desire discrepancy: A position statement of the European Society for Sexual Medicine. Sexual Medicine, 8(2), 121–131. https://doi.org/10.1016/j.esxm.2020.02.008
  • Dhillon, S., & Keam, S. J. (2019). Bremelanotide: First approval. Drugs, 79(14), 1599–1606. https://doi.org/10.1007/s40265-019-01187-w
  • Eplov, L., Giraldi, A., Davidsen, M., Garde, K., & Kamper-Jørgensen, F. (2007). Original Research—Epidemiology: Sexual desire in a nationally representative Danish population. The Journal of Sexual Medicine, 4(1), 47–56. https://doi.org/10.1111/j.1743-6109.2006.00396.x
  • Flake, J. K., & Fried, E. I. (2020). Measurement shmeasurement: Questionable measurement practices and how to avoid them. Advances in Methods and Practices in Psychological Science, 3(4), 456–465. https://doi.org/10.1177/2515245920952393
  • Food and Drug Administration. (2014). Scientific workshop on female sexual interest/arousal disorder. https://www.fda.gov/media/130003/download
  • Forbes, M. K., Baillie, A. J., & Schniering, C. A. (2014). Critical flaws in the Female Sexual Function Index and the International Index of Erectile Function. The Journal of Sex Research, 51(5), 485–491. https://doi.org/10.1080/00224499.2013.876607
  • Fried, E. I. (2017). The 52 symptoms of major depression: Lack of content overlap among seven common depression scales. Journal of Affective Disorders, 208, 191–197. https://doi.org/10.1016/j.jad.2016.10.019
  • Fried, E. I., Flake, J. K., & Robinaugh, D. J. (2022). Revisiting the theoretical and methodological foundations of depression measurement. Nature Reviews Psychology, 1(6), 358–368. https://doi.org/10.1038/s44159-022-00050-2
  • Fried, E. I., & Nesse, R. M. (2015). Depression sum-scores don’t add up: Why analyzing specific depression symptoms is essential. BMC Medicine, 13(1), 72. https://doi.org/10.1186/s12916-015-0325-4
  • Fried, E. I., Nesse, R. M., & Gong, Q. (2014). The impact of individual depressive symptoms on impairment of psychosocial functioning. PLoS One, 9(2), e90311. https://doi.org/10.1371/journal.pone.0090311
  • Giraldi, A., Kristensen, E., & Sand, M. (2015). Endorsement of models describing sexual response of men and women with a sexual partner: An online survey in a population sample of Danish adults ages 20–65 years. The Journal of Sexual Medicine, 12(1), 116–128. https://doi.org/10.1111/jsm.12720
  • Goldstein, I., Kim, N. N., Clayton, A. H., DeRogatis, L. R., Giraldi, A., Parish, S. J., Pfaus, J., Simon, J. A., Kingsberg, S. A., Meston, C., Stahl, S. M., Wallen, K., & Worsley, R. (2017). Hypoactive sexual desire disorder: International Society for the Study of Women’s Sexual Health (ISSWSH) expert consensus panel review. Mayo Clinic Proceedings, 92, 114–128. https://doi.org/10.1016/j.mayocp.2016.09.018
  • Graham, C. A., Boynton, P. M., & Gould, K. (2017). Women’s sexual desire: Challenging narratives of “dysfunction.” European Psychologist, 22(1), 27–38. https://doi.org/10.1027/1016-9040/a000282
  • Graham, C. A., Brotto, L. A., & Zucker, K. J. (2014). Response to Balon and Clayton (2014): Female sexual interest/arousal disorder is a diagnosis more on firm ground than thin air. Archives of Sexual Behavior, 43(7), 1231–1234. https://doi.org/10.1007/s10508-013-0248-0
  • Graham, C. A., Mercer, C. H., Tanton, C., Jones, K. G., Johnson, A. M., Wellings, K., & Mitchell, K. R. (2017). What factors are associated with reporting lacking interest in sex and how do these vary by gender? Findings from the third British national survey of sexual attitudes and lifestyles. BMJ Open, 7(9), e016942. https://doi.org/10.1136/bmjopen-2017-016942
  • Graham, C. A., Sanders, S. A., Milhausen, R. R., & McBride, K. R. (2004). Turning on and turning off: A focus group study of the factors that affect women’s sexual arousal. Archives of Sexual Behavior, 33(6), 527–538. https://doi.org/10.1023/B:ASEB.0000044737.62561.fd
  • Hamilton, L. D., & Julian, A. M. (2014). The relationship between daily hassles and sexual function in men and women. Journal of Sex & Marital Therapy, 40(5), 379–395. https://doi.org/10.1080/0092623X.2013.864364
  • Hart, B., Lundh, A., & Bero, L. (2012). Effect of reporting bias on meta-analyses of drug trials: Reanalysis of meta-analyses. BMJ, 344(jan03 1), d7202. https://doi.org/10.1136/bmj.d7202
  • Healy, D., & Cattell, D. (2003). Interface between authorship, industry and science in the domain of therapeutics. British Journal of Psychiatry, 183(1), 22–27. https://doi.org/10.1192/bjp.183.1.22
  • Hedges, L. V., & Olkin, I. (1985). Statistical methods for meta-analysis. Academic Press.
  • Hogenmiller, A., Aless, H., & Fugh-Berman, A. (2017, June 14). The score is even. The Hastings Center. https://www.thehastingscenter.org/the-score-is-even/
  • Hughes, S., Cohen, D., & Jaggi, R. (2014). Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: A cross-sectional study. BMJ Open, 4(7), e005535. https://doi.org/10.1136/bmjopen-2014-005535
  • Hyman, S. E. (2010). The diagnosis of mental disorders: The problem of reification. Annual Review of Clinical Psychology, 6(1), 155–179. https://doi.org/10.1146/annurev.clinpsy.3.022806.091532
  • Johannes, C. B., Clayton, A. H., Odom, D. M., Rosen, R. C., Russo, P. A., Shifren, J. L., & Monz, B. U. (2009). Distressing sexual problems in United States women revisited: Prevalence after accounting for depression. The Journal of Clinical Psychiatry, 70(12), 1698–1706. https://doi.org/10.4088/JCP.09m05390gry
  • Kaplan, H. S. (1979). Disorders of sexual desire. Brunner/Mazel.
  • Kazdin, A. E. (2006). Arbitrary metrics: Implications for identifying evidence-based treatments. American Psychologist, 61(1), 42–49. https://doi.org/10.1037/0003-066X.61.1.42
  • King, M., Holt, V., & Nazareth, I. (2007). Women’s views of their sexual difficulties: Agreement and disagreement with clinical diagnoses. Archives of Sexual Behavior, 36(2), 281–288. https://doi.org/10.1007/s10508-006-9090-y
  • Kingsberg, S. A., Clayton, A. H., Portman, D., Williams, L. A., Krop, J., Jordan, R., Lucas, J., & Simon, J. A. (2019). Bremelanotide for the treatment of hypoactive sexual desire disorder: Two randomized phase 3 trials. Obstetrics and Gynecology, 134(5), 899–908. https://doi.org/10.1097/AOG.0000000000003500
  • Kingsberg, S., Lucas, J., Jordan, R., & Spana, C. (2017). Efficacy of bremelanotide for hypoactive sexual desire disorder (RECONNECT Study). The Journal of Sexual Medicine, 14(5), E335.
  • Kirsch, I., & Moncrieff, J. (2007). Clinical trials and the response rate illusion. Contemporary Clinical Trials, 28(4), 348–351. https://doi.org/10.1016/j.cct.2006.10.012
  • Koochaki, P., Revicki, D., Wilson, H., Pokrzywinski, R., Jordan, R., Lucas, J., Williams, L. A., Sadiq, A., & Krop, J. (2021). The patient experience of premenopausal women treated with bremelanotide for hypoactive sexual desire disorder: RECONNECT exit study results. Journal of Women’s Health, 30(4), 587–595. https://doi.org/10.1089/jwh.2020.8460
  • Krasnow, S. S., & Maglio, A.-S. (2021). Female sexual desire: What helps, what hinders, and what women want. Sexual and Relationship Therapy, 36(4), 318–346. https://doi.org/10.1080/14681994.2019.1626011
  • Laan, E., & Both, S. (2011). Sexual desire and arousal disorders in women. In R. Balon (Ed.), Sexual dysfunction: Beyond the brain-body connection (pp. 16–34). Karger.
  • Lim-Watson, M. Z., Hays, R. D., Kingsberg, S., Kallich, J. D., & Murimi-Worstell, I. B. (2022). A systematic literature review of health-related quality of life measures for women with hypoactive sexual desire disorder and female sexual interest/arousal disorder. Sexual Medicine Reviews, 10(1), 23–41. https://doi.org/10.1016/j.sxmr.2021.07.003
  • MacCallum, R. C., Zhang, S., Preacher, K. J., & Rucker, D. D. (2002). On the practice of dichotomization of quantitative variables. Psychological Methods, 7(1), 19. https://doi.org/10.1037/1082-989x.7.1.19
  • Masters, W. H., & Johnson, V. E. (1966). Human sexual response. Little, Brown.
  • Mathieu, S., Boutron, I., Moher, D., Altman, D. G., & Ravaud, P. (2009). Comparison of registered and published primary outcomes in randomized controlled trials. JAMA, 302(9), 977–984. https://doi.org/10.1001/jama.2009.1242
  • Mayo-Wilson, E., Li, T., Fusco, N., & Dickersin, K., & Investigators, for the M. (2018). Practical guidance for using multiple data sources in systematic reviews and meta-analyses (with examples from the MUDS study). Research Synthesis Methods, 9(1), 2–12. https://doi.org/10.1002/jrsm.1277
  • Meana, M. (2010). Elucidating women’s (hetero) sexual desire: Definitional challenges and content expansion. The Journal of Sex Research, 47(2–3), 104–122. https://doi.org/10.1080/00224490903402546
  • Meixel, A., Yanchar, E., & Fugh-Berman, A. (2015). Hypoactive sexual desire disorder: Inventing a disease to sell low libido. Journal of Medical Ethics, 41(10), 859–862. https://doi.org/10.1136/medethics-2014-102596
  • Meston, C. M. (2003). Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. Journal of Sex & Marital Therapy, 29(1), 39–46. https://doi.org/10.1080/713847100
  • Meyer-Bahlburg, H. F., & Dolezal, C. (2007). The Female Sexual Function Index: A methodological critique and suggestions for improvement. Journal of Sex & Marital Therapy, 33(3), 217–224. https://doi.org/10.1080/00926230701267852
  • Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010). CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ, 340(mar23 1), c869. https://doi.org/10.1136/bmj.d6131
  • Mokkink, L. B., De Vet, H. C., Prinsen, C. A., Patrick, D. L., Alonso, J., Bouter, L. M., & Terwee, C. B. (2018). COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Quality of Life Research, 27(5), 1171–1179. https://doi.org/10.1007/s11136-017-1765-4
  • Moynihan, R. (2003). The making of a disease: Female sexual dysfunction. British Medical Journal, 326(7379), 45–47. https://doi.org/10.1136/bmj.326.7379.45
  • Neijenhuijs, K. I., Hooghiemstra, N., Holtmaat, K., Aaronson, N. K., Groenvold, M., Holzner, B., Terwee, C. B., Cuijpers, P., & Verdonck-de Leeuw, I. M. (2019). The Female Sexual Function Index (FSFI)—A systematic review of measurement properties. The Journal of Sexual Medicine, 16(5), 640–660. https://doi.org/10.1016/j.jsxm.2019.03.001
  • O’Loughlin, J. I., Basson, R., & Brotto, L. A. (2018). Women with hypoactive sexual desire disorder versus sexual interest/arousal disorder: An empirical test of raising the bar. The Journal of Sex Research, 55(6), 734–746. https://doi.org/10.1080/00224499.2017.1386764
  • Orben, A., & Przybylski, A. K. (2019). The association between adolescent well-being and digital technology use. Nature Human Behaviour, 3(2), 173–182. https://doi.org/10.1038/s41562-018-0506-1
  • Parish, S. J., Cottler-Casanova, S., Clayton, A. H., McCabe, M. P., Coleman, E., & Reed, G. M. (2021). The evolution of the female sexual disorder/dysfunction definitions, nomenclature, and classifications: A review of DSM, ICSM, ISSWSH, and ICD. Sexual Medicine Reviews, 9(1), 36–56. https://doi.org/10.1016/j.sxmr.2020.05.001
  • Pyke, R. E. (2021). FDA decisions on measures of hypoactive sexual desire disorder in women: A history, with grounds to consider clinical judgment. Sexual Medicine Reviews, 9(2), 186–193. https://doi.org/10.1016/j.sxmr.2020.12.001
  • Regan, P. C., & Atkins, L. (2006). Sex differences and similarities in frequency and intensity of sexual desire. Social Behavior and Personality, 34(1), 95–102. https://doi.org/10.2224/sbp.2006.34.1.95
  • Reuters. (2007, September 10). Palatin says King Pharma ends drug agreement on FDA concern. Reuters. https://www.reuters.com/article/idUSWNAS370720070910
  • Revicki, D. A., Clayton, A. H., Stouch, B. C., Portman, D. J., Kingsberg, S. A., DeRogatis, L. R., & Jordan, R. (2018, February 20). Developing clinically meaningful responder thresholds for primary endpoints for clinical trials in premenopausal women with hypoactive sexual desire disorder. International Society for CNS Trials and Methodology.
  • Revicki, D. A., Margolis, M. K., Bush, E. N., DeRogatis, L. R., & Hanes, V. (2011). Content validity of the Female Sexual Function Index (FSFI) in pre-and postmenopausal women with hypoactive sexual desire disorder. The Journal of Sexual Medicine, 8(8), 2237–2245. https://doi.org/10.1111/j.1743-6109.2011.02312.x
  • Revicki, D. A., Margolis, M. K., Fisher, W., Rosen, R. C., Kuppermann, M., Hanes, V., & Sand, M. (2012). Evaluation of the sexual desire relationship distress scale (SDRDS) in women with hypoactive sexual desire disorder. The Journal of Sexual Medicine, 9(5), 1344–1354. https://doi.org/10.1111/j.1743-6109.2012.02679.x
  • Rosen, R. (2000). The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy, 26(2), 191–208. https://doi.org/10.1080/009262300278597
  • Rubin, J. D., Conley, T. D., Klein, V., Liu, J., Lehane, C. M., & Dammeyer, J. (2019). A cross-national examination of sexual desire: The roles of ‘gendered cultural scripts’ and ‘sexual pleasure’ in predicting heterosexual women’s desire for sex. Personality and Individual Differences, 151, 109502. https://doi.org/10.1016/j.paid.2019.07.012
  • Safarinejad, M. R., & Hosseini, S. Y. (2008). Salvage of sildenafil failures With bremelanotide: A randomized, double-blind, placebo controlled study. Journal of Urology, 179(3), 1066–1071. https://doi.org/10.1016/j.juro.2007.10.063
  • Sand, M., & Fisher, W. A. (2007). Women’s endorsement of models of female sexual response: The nurses’ sexuality study. The Journal of Sexual Medicine, 4(3), 708–719. https://doi.org/10.1111/j.1743-6109.2007.00496.x
  • Schulz, K. F., Altman, D. G., Moher, D., & Group, C. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. PLoS Medicine, 7(3), e1000251. https://doi.org/10.1371/journal.pmed.1000251
  • Sechrest, L., McKnight, P., & McKnight, K. (1996). Calibration of measures for psychotherapy outcome studies. American Psychologist, 51(10), 1065–1071. https://doi.org/10.1037/0003-066X.51.10.1065
  • Shadiack, A. M., Sharma, S. D., Earle, D. C., Spana, C., & Hallam, T. J. (2007). Melanocortins in the treatment of male and female sexual dysfunction. Current Topics in Medicinal Chemistry, 7(11), 1137–1144. https://doi.org/10.2174/156802607780906681
  • Shaw, M., Cloose, L. J. R., Luong, R., Elbaz, S., & Flake, J. K. (2020). Measurement practices in large-scale replications: Insights from many labs 2. Canadian Psychology / Psychologie Canadienne, 61(4), 289–298. https://doi.org/10.1037/cap0000220
  • Shihata, S., Johnson, A. R., Erceg-Hurn, D. M., & McEvoy, P. M. (2021). Measurement invariance of disorder-specific and transdiagnostic measures of repetitive negative thinking. Assessment, 10731911211028656. https://doi.org/10.1177/10731911211028657
  • Spielmans, G. I. (2021). Re-analyzing phase III bremelantoide trials for “hypoactive sexual desire disorder” in women. The Journal of Sex Research, 58(9), 1085–1105. https://doi.org/10.1080/00224499.2021.1885601
  • Steidle, C. P., Zinner, N. R., Karlin, G., Salzstein, D., & Fischkoff, S. (2007). 1177: Phase IIB study of bremelanotide in the treatment of ED in diabetic males. Journal of Urology, 177(4S), 388–388. https://doi.org/10.1016/S0022-5347(18)31391-0
  • Stephenson, K. R., Toorabally, N., Lyons, L., & Meston, C. (2016). Further validation of the Female Sexual Function Index: Specificity and associations with clinical interview data. Journal of Sex & Marital Therapy, 42(5), 448–461.
  • Tavernise, S., & Pollack, A. (2015, June 13). Aid to women, or bottom line? Advocates split on libido pill. The New York Times. https://www.nytimes.com/2015/06/14/us/aid-to-women-or-bottom-line-advocates-split-on-libido-pill.html
  • ter Kuile, M. M., Vigeveno, D., & Laan, E. (2007). Preliminary evidence that acute and chronic daily psychological stress affect sexual arousal in sexually functional women. Behaviour Research and Therapy, 45(9), 2078–2089. https://doi.org/10.1016/j.brat.2007.03.006
  • Terwee, C. B., Bot, S. D. M., de Boer, M. R., van der Windt, D. A. W. M., Knol, D. L., Dekker, J., Bouter, L. M., & de Vet, H. C. W. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42. https://doi.org/10.1016/j.jclinepi.2006.03.012
  • Thomas, H. N., Hamm, M., Hess, R., Borrero, S., & Thurston, R. C. (2017). Patient-centered outcomes and treatment preferences regarding sexual problems: A qualitative study among midlife women. The Journal of Sexual Medicine, 14(8), 1011–1017. https://doi.org/10.1016/j.jsxm.2017.05.014
  • Tiefer, L. (2006). Female sexual dysfunction: A case study of disease mongering and activist resistance. PLOS Medicine, 3(4), e178. https://doi.org/10.1371/journal.pmed.0030178
  • Toates, F. (2009). An integrative theoretical framework for understanding sexual motivation, arousal, and behavior. The Journal of Sex Research, 46(2–3), 168–193. https://doi.org/10.1080/00224490902747768
  • Turner, E. H. (2013). How to access and process FDA drug approval packages for use in research. BMJ, 347(oct14 2), f5992. https://doi.org/10.1136/bmj.f5992
  • Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358(3), 252–260. https://doi.org/10.1056/NEJMsa065779
  • Ückert, S., Bannowsky, A., Albrecht, K., & Kuczyk, M. A. (2014). Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: Results from basic research and clinical studies. Expert Opinion on Investigational Drugs, 23(11), 1477–1483. https://doi.org/10.1517/13543784.2014.934805
  • United States Food and Drug Administration. (2019a). Prescribing information for bremelanotide. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf
  • United States Food and Drug Administration. (2019b). New drug application multi-disciplinary review and evaluation standard 210557: Vyleesi/Bremelanotide. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/210557Orig1s000TOC.cfm
  • Van De Schoot, R., Schmidt, P., De Beuckelaer, A., Lek, K., & Zondervan-Zwijnenburg, M. (2015). Editorial: Measurement invariance. Frontiers in Psychology, 6. https://doi.org/10.3389/fpsyg.2015.01064
  • Velten, J. (2017). The dual control model of sexual response: Relevance of sexual excitation and sexual inhibition for sexual function. Current Sexual Health Reports, 9(2), 90–97. https://doi.org/10.1007/s11930-017-0108-3
  • Weidman, A. C., Steckler, C. M., & Tracy, J. L. (2017). The jingle and jangle of emotion assessment: Imprecise measurement, casual scale usage, and conceptual fuzziness in emotion research. Emotion, 17(2), 267. https://doi.org/10.1037/emo0000226
  • West, S. L., D’Aloisio, A. A., Agans, R. P., Kalsbeek, W. D., Borisov, N. N., & Thorp, J. M. (2008). Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Archives of Internal Medicine, 168(13), 1441–1449. https://doi.org/10.1001/archinte.168.13.1441
  • White, W. B., Myers, M. G., Jordan, R., & Lucas, J. (2017). Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide. Journal of Hypertension, 35(4), 761–768. https://doi.org/10.1097/HJH.0000000000001221
  • Wiegel, M., Meston, C., & Rosen, R. (2005). The Female Sexual Function Index (FSFI): Cross-validation and development of clinical cutoff scores. Journal of Sex & Marital Therapy, 31(1), 1–20. https://doi.org/10.1080/00926230590475206
  • Willoughby, B. J., Farero, A. M., & Busby, D. M. (2014). Exploring the effects of sexual desire discrepancy among married couples. Archives of Sexual Behavior, 43(3), 551–562. https://doi.org/10.1007/s10508-013-0181-2
  • World Health Organization. (2022). Hypoactive sexual desire dysfunction. International classification of disease and related health problems (11th ed.). World Health Organization. https://icd.who.int/browse11/l-m/en#/http:%2f%2fid.who.int%2ficd%2fentity%2f1189253773
  • Wouters, C. (2013). “No sex under my roof”: Teenage sexuality in the USA and in the Netherlands since the 1880s. Política y Sociedad, 50(2), 421–452. https://doi.org/10.5209/rev_POSO.2013.v50.n2.40026

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.